Toggle navigation
Home
Search
Services
Blog
Contact
About
Immunoglobulin T-Cell Stimulators for Cancer Therapy
Fry, Kirk
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 11 grants from Kirk Fry
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cadherin-p120 signaling in motility and invasiveness
Oncobiology Training Program
Human Transposable Element
Phase II Wbh and Ifosfamide/Carboplatin/Etoposide (ICE) Therapy in Sarcoma
Selective Injury of Microvasculature by Pulsed Radiation
Recently added grants:
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
TB detection in children using a novel stool-based GeneXpert assay
Modeling immunity with a hybrid lymph node tissue-chip
Induction of food allergen-specific neonatal tolerance through breast milk
Impact of versican deficiency on the innate immune response to influenza virus
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057773-000
Application #
3613362
Study Section
Project Start
1985-09-20
Project End
Budget Start
1985-09-20
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Comments
Be the first to comment on this grant